In December 2021, Medicines for Ireland (MFI) signed a new Framework Agreement on Supply and Pricing of Medicines 2021-2025 with the Department of Health, the Department of Public Expenditure and Reform, and with the Health Service Executive (HSE).

 

The text of the ‘Framework Agreement on the supply and pricing of non-originator, generic, biosimilar, and hybrid medicines’ can be viewed here.